|
Volumn 93, Issue , 2012, Pages 331-334
|
Determination of dopamine in pharmaceutical formulation using enhanced luminescence from europium complex
|
Author keywords
Ascorbic acid; Dipicolinic acid; Dopamine; Europium; Fluorescence
|
Indexed keywords
ASCORBIC ACIDS;
CLINICAL MEDICINE;
DIPICOLINIC ACIDS;
DOPAMINE;
ENHANCED LUMINESCENCE;
EUROPIUM COMPLEX;
FLUORIMETRIC DETERMINATION;
GOOD STABILITY;
INDEPENDENT MEASUREMENT;
LIMIT OF DETECTION;
LINEAR RESPONSE;
OPERATIONAL PARAMETERS;
OPTIMUM CONDITIONS;
PARKINSON'S DISEASE;
PERIPHERAL NERVOUS SYSTEM;
PHARMACEUTICAL FORMULATION;
RELATIVE STANDARD DEVIATIONS;
REPRODUCIBILITIES;
DISEASES;
EUROPIUM;
FLUORESCENCE;
KETONES;
ORGANIC ACIDS;
NEUROPHYSIOLOGY;
ASCORBIC ACID;
COORDINATION COMPOUND;
DIPICOLINIC ACID;
DOPAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
DRUG;
EUROPIUM;
PICOLINIC ACID DERIVATIVE;
ARTICLE;
CHEMISTRY;
EVALUATION;
LIMIT OF DETECTION;
METHODOLOGY;
REPRODUCIBILITY;
SPECTROFLUOROMETRY;
ASCORBIC ACID;
COORDINATION COMPLEXES;
DOPAMINE;
DOPAMINE AGENTS;
EUROPIUM;
LIMIT OF DETECTION;
PHARMACEUTICAL PREPARATIONS;
PICOLINIC ACIDS;
REPRODUCIBILITY OF RESULTS;
SPECTROMETRY, FLUORESCENCE;
|
EID: 84860179664
PISSN: 13861425
EISSN: None
Source Type: Journal
DOI: 10.1016/j.saa.2012.03.031 Document Type: Article |
Times cited : (13)
|
References (30)
|